Literature DB >> 2693114

Vitamin E and cardiovascular disease.

J Kleijnen1, P Knipschild, G ter Riet.   

Abstract

Randomized clinical trials of the effects of Vitamin E on complaints of intermittent claudication and angina pectoris are reviewed, and their methodological shortcomings are considered. Mechanisms by which Vitamin E might act in cardiovascular disease are discussed. The evidence about the possible pharmacological actions of Vitamin E supports the need for randomized clinical trials. It is concluded that Vitamin E may have a positive effect, especially in intermittent claudication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693114     DOI: 10.1007/bf00562540

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol.

Authors:  A M BOYD; J MARKS
Journal:  Angiology       Date:  1963-04       Impact factor: 3.619

2.  Alpha-tocopherol in the treatment of intermittent claudication: a preliminary report.

Authors:  H T WILLIAMS; L J CLEIN; R A MACBETH
Journal:  Can Med Assoc J       Date:  1962-09-08       Impact factor: 8.262

3.  The treatment of intermittent claudication with vitamin E.

Authors:  M HAMILTON; G M WILSON; P ARMITAGE; J T BOYD
Journal:  Lancet       Date:  1953-02-21       Impact factor: 79.321

4.  Negative results of tocopherol therapy in cardiovascular disease.

Authors:  C K DONEGAN; A L MESSER
Journal:  Am J Med Sci       Date:  1949-03       Impact factor: 2.378

5.  Vitamin E in intermittent claudication.

Authors:  A H RATCLIFFE
Journal:  Lancet       Date:  1949-12-17       Impact factor: 79.321

6.  The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol).

Authors:  K Haeger
Journal:  Vasc Dis       Date:  1968-12

7.  Long-term study of alpha-tocopherol in intermittent claudication.

Authors:  K Haeger
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

8.  Vitamin E does not modify HDL-cholesterol.

Authors:  D R Howard; C A Rundell; J G Batsakis
Journal:  Am J Clin Pathol       Date:  1982-01       Impact factor: 2.493

9.  Vitamin E and the heart: possible role as antioxidant.

Authors:  R Ferrari; O Visioli; C Guarnieri; M Caldarera
Journal:  Acta Vitaminol Enzymol       Date:  1983

10.  Influence of vitamin E on physical performance.

Authors:  I Simon-Schnass; H Pabst
Journal:  Int J Vitam Nutr Res       Date:  1988       Impact factor: 1.784

View more
  3 in total

1.  Effect of vitamin E on the platelet xanthine oxidase and lipid peroxidation in the patients of myocardial infarction.

Authors:  Rashmi Raghuvanshi; M Chandra; P C Misra; M K Misra
Journal:  Indian J Clin Biochem       Date:  2005-01

Review 2.  Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data.

Authors:  R Marchioli; C Schweiger; G Levantesi; L Tavazzi; F Valagussa
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 3.  Vitamin E in extrapyramidal disorders.

Authors:  L Bischot; G Van den Brink; A J Porsius
Journal:  Pharm World Sci       Date:  1993-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.